[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: BDB-001: Dosing plan: BDB-001 for infusion; 300 mg/person/time; intravenous injection; at days 1; 2; 3; 5;7;9;11; and 13;8 times in total (dosage and frequency of administration can be adjusted according to the progression of the disease).BDB-001 is a recombinant humanized anti-human C5a IgG4\u00ce\u00ba monoclonal antibody for injection; which contains a total of 1328 amino acids and is composed of two heavy chains containing 446 amino acids and two light chains containing 218 amino acids.Control Intervention1: Standard of CARE: Standard of CARE for Management of COVID19 as per National Guidelines will be followed as SOC", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: BDB-001: Dosing plan: BDB-001 for infusion; 300 mg/person/time; intravenous injection; at days 1; 2; 3; 5;7;9;11; and 13;8 times in total (dosage and frequency of administration can be adjusted according to the progression of the disease).BDB-001 is a recombinant humanized anti-human C5a IgG4\u00ce\u00ba monoclonal antibody for injection; which contains a total of 1328 amino acids and is composed of two heavy chains containing 446 amino acids and two light chains containing 218 amino acids.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of CARE: Standard of CARE for Management of COVID19 as per National Guidelines will be followed as SOC", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 187, "treatment_name": "Bdb-001", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: BDB-001: Dosing plan: BDB-001 for infusion; 300 mg/person/time; intravenous injection; at days 1; 2; 3; 5;7;9;11; and 13;8 times in total (dosage and frequency of administration can be adjusted according to the progression of the disease).BDB-001 is a recombinant humanized anti-human C5a IgG4\u00ce\u00ba monoclonal antibody for injection; which contains a total of 1328 amino acids and is composed of two heavy chains containing 446 amino acids and two light chains containing 218 amino acids.Control Intervention1: Standard of CARE: Standard of CARE for Management of COVID19 as per National Guidelines will be followed as SOC", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: BDB-001: Dosing plan: BDB-001 for infusion; 300 mg/person/time; intravenous injection; at days 1; 2; 3; 5;7;9;11; and 13;8 times in total (dosage and frequency of administration can be adjusted according to the progression of the disease).BDB-001 is a recombinant humanized anti-human C5a IgG4\u00ce\u00ba monoclonal antibody for injection; which contains a total of 1328 amino acids and is composed of two heavy chains containing 446 amino acids and two light chains containing 218 amino acids.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of CARE: Standard of CARE for Management of COVID19 as per National Guidelines will be followed as SOC", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: BDB-001: Dosing plan: BDB-001 for infusion; 300 mg/person/time; intravenous injection; at days 1; 2; 3; 5;7;9;11; and 13;8 times in total (dosage and frequency of administration can be adjusted according to the progression of the disease).BDB-001 is a recombinant humanized anti-human C5a IgG4\u00ce\u00ba monoclonal antibody for injection; which contains a total of 1328 amino acids and is composed of two heavy chains containing 446 amino acids and two light chains containing 218 amino acids.Control Intervention1: Standard of CARE: Standard of CARE for Management of COVID19 as per National Guidelines will be followed as SOC", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: BDB-001: Dosing plan: BDB-001 for infusion; 300 mg/person/time; intravenous injection; at days 1; 2; 3; 5;7;9;11; and 13;8 times in total (dosage and frequency of administration can be adjusted according to the progression of the disease).BDB-001 is a recombinant humanized anti-human C5a IgG4\u00ce\u00ba monoclonal antibody for injection; which contains a total of 1328 amino acids and is composed of two heavy chains containing 446 amino acids and two light chains containing 218 amino acids.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Standard of CARE: Standard of CARE for Management of COVID19 as per National Guidelines will be followed as SOC", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]